Stemedica and Gyeonggi Province, Korea join forces
(Source: June 2008; Stemedica Cell Technologies, Inc.)
Leaders from Stemedica Cell Technologies and the Gyeonggi Province, Republic of Korea’s government, gathered in Palo Alto, California to sign a Memorandum of Understanding that will stimulate economic development and technological advancement between the parties.
Stemedica Cell Technologies, Inc. Strengthens Clinical Leadership Team
(Source: December 2007; Stemedica Cell Technologies, Inc.)
Stemedica Cell Technologies (“Stemedica”) announced today the addition of Paul A. Frohna, MD, PhD, PharmD, to the company’s management team as Vice President, Clinical Research and Regulatory Affairs. Paul joins Stemedica from FibroGen, Inc. where he has been serving as Acting Vice President for Clinical Development.
Stemedica and Hospital Angeles announce partnership
(Source: September 2007; Stemedica Cell Technologies, Inc.)
Stemedica Cell Technologies announced at a media conference yesterday that it has established a partnership with Hospital Angeles -Tijuana, part of Grupo Angeles Servicios de Salud, the largest hospital chain in Mexico. The partnership will provide adult stem cell treatments to patients with a wide variety of medical conditions including Alzheimer's, Parkinson's, Multiple Sclerosis, Muscular Dystrophy, Stroke, Ischemic Brain Trauma's, Spinal Cord Injuries, Diabetes, Macular Degeneration, and Diabetic Retinopathy, as well as skin, scar and bone regeneration.
Stemedica Cell Technologies, Inc., along with the Premier of Bermuda and his wife, announce the formation of the Brown-Darrell Research Clinic for Stem Cell Treatment
(Source: July 2007; Stemedica Cell Technologies, Inc.)
Stemedica Cell Technologies, Inc. in collaboration with and support of Dr. and Wanda Brown announces a new stem cell research center to be opened in Bermuda in late 2007. Jointly sponsored by Stemedica and Dr. Ewart Brown, Premier of Bermuda and his wife, Wanda Henton Brown, the clinic will be named the Brown-Darrell Research Clinic after Dr. Brown's parents. The clinic will be accredited as a Licensed Treatment Center by Stemedica, offering revolutionary treatment using adult stem cell technologies for conditions such as Alzheimer's, Parkinson's disease, spinal cord injuries, diabetes and diseases of the eye.
Stemedica Cell Technologies and partners host Adult Stem Cells & HIV/AIDS roundtable
(Source: June 2007; Stemedica Stem Cell Technologies, Incorporated)
Stemedica Cell Technologies, Inc., Project Concern International and Gen-Probe, Incorporated, co-hosted a roundtable session in San Diego in March 2007. The goal of the session was to explore ways in which adult stem cells can be applied in the fight to prevent and treat HIV/AIDS. The event included participants from The Burnham Institute, UCSF, MIT, UCLA, UCSD, Kaunda Children's Foundation, Mildmay HIV/AIDS Health Center (Uganda), the Elizabeth Glaser Pediatric AIDS Foundation, Project Concern International, and Power of Love Foundation, Gen-Probe, Incorporated and Stemedica Cell Technologies, Inc.
Researchers track human stem cells transplanted into rat brain
http://med.stanford.edu/news_releases/2007/june/steinberg.html
(Source: June 2007; Stanford University School of Medicine)
Human neural stem cells that were transplanted into the brains of rodents successfully navigated toward areas damaged by stroke, a new study shows. The study, conducted by researchers at the Stanford University of Medicine, was published in the June 4 advance online version of the Proceedings of the National Academy of Science. The findings could make it possible for tracking the progress and success of human stem cells implanted into humans, which can be used to treat such disorders as stroke or Parkinson's.
FSU engineering professor growing bone in a lab
http://www.fsu.edu/news/2007/05/21/generating.bone/
(Source: May 2007; Florida State University)
The research being conducted at Florida State University could lead to the development of new technologies for treating bone loss due to disease or injury. Teng Ma, an Associate Professor of Chemical and Biomedical Engineering, received a four-year grant from the U.S. Department of Defense for this important research. This research can relieve the supply limitations and rejection risks that accompany donor grafts by enabling the patient's own adult stems cells to be one component in the creation of artificial grafts.
Scripps Research Institute Team awarded $17 million grant to develop therapeutic use of Adult Stem Cells to treat eye diseases
http://www.scripps.edu/news/press/052907.html
(Source: May 2007; The Scripps Research Institute)
The Friedlander lab at the Scripps Clinic has be awarded a $17M grant from the National Eye Institute to develop methods for using adult stem cells to treat retinal diseases. The project, which will run over the next five years, will be conducted in partnership with six other laboratory groups at Scripps Research. The effort will explore new technologies and approaches for using adult stem cells to treat conditions including diabetic retinopathy, age related macular degeneration, glaucoma, and retinitis pigmentosa.
Researchers use Adult Stem Cells to create soft tissue
http://www.cumc.columbia.edu/news/press_releases/Mao_NIH07.html
(Source: June 2007; Columbia University Medical Center)
Researchers from Columbia University Medical Center received a $2.5 million grant from the National Institute of Biomedical Imaging and Bioengineering to use stem cells to engineer soft tissue, developing a process that should ultimately allow scientists to use a patient's own stem cells to develop tissue for facial reconstruction following disfiguring injuries from war, cancer surgery or accidents.